Salvinorinas A (Lithuanian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Salvinorinas A" in Lithuanian language version.

refsWebsite
Global rank Lithuanian rank
4th place
12th place
2nd place
10th place
5th place
16th place
low place
low place
504th place
212th place
1st place
1st place
low place
low place

cyjack.com

doi.org

  • Prisinzano TE (2005). „Psychopharmacology of the hallucinogenic sage Salvia divinorum“. Life Sci. 78 (5): 527–31. doi:10.1016/j.lfs.2005.09.008. PMID 16213533.
  • Harding, Wayne W.; Schmidt, Matthew; Tidgewell, Kevin; Kannan, Pavitra; Holden, Kenneth G.; Gilmour, Brian; Navarro, Hernan; Rothman, Richard B.; Prisinzano, Thomas E. (2006-01-01). „Synthetic Studies of Neoclerodane Diterpenes from Salvia d ivinorum : Semisynthesis of Salvinicins A and B and Other Chemical Transformations of Salvinorin A“. Journal of Natural Products. 69 (1): 107–112. doi:10.1021/np050398i. ISSN 0163-3864. PMC 2544632. PMID 16441078.
  • Imanshahidi M, Hosseinzadeh H (2006). „The pharmacological effects of Salvia species on the central nervous system“. Phytother Res. 20 (6): 427–37. doi:10.1002/ptr.1898. PMID 16619340.
  • Zhang Y, Butelman ER, Schlussman SD, Ho A, Kreek MJ (2005). „Effects of the plant-derived hallucinogen salvinorin A on basal dopamine levels in the caudate putamen and in a conditioned place aversion assay in mice: agonist actions at kappa opioid receptors“. Psychopharmacology (Berl.). 179 (3): 551–8. doi:10.1007/s00213-004-2087-0. PMID 15682306.{{cite journal}}: CS1 priežiūra: multiple names: authors list (link)
  • Bigham AK, Munro TA, Rizzacasa MA, Robins-Browne RM (2003). „Divinatorins A-C, new neoclerodane diterpenoids from the controlled sage Salvia divinorum“. J. Nat. Prod. 66 (9): 1242–4. doi:10.1021/np030313i. PMID 14510607.{{cite journal}}: CS1 priežiūra: multiple names: authors list (link)
  • Munro TA, Rizzacasa MA (2003). „Salvinorins D-F, new neoclerodane diterpenoids from Salvia divinorum, and an improved method for the isolation of salvinorin A“. J. Nat. Prod. 66 (5): 703–5. doi:10.1021/np0205699. PMID 12762813.
  • Lingham AR, Hügel HM, Rook TJ (2006). „Studies Towards the Synthesis of Salvinorin A“. Aust. J. Chem. 59 (5): 340–348. doi:10.1071/CH05338.{{cite journal}}: CS1 priežiūra: multiple names: authors list (link)
  • Scheerer JR, Lawrence JF, Wang GC, Evans DA (2007). „Asymmetric synthesis of salvinorin A, a potent kappa opioid receptor agonist“. J. Am. Chem. Soc. 129 (29): 8968–9. doi:10.1021/ja073590a. PMID 17602636.{{cite journal}}: CS1 priežiūra: multiple names: authors list (link)

google.co.uk

scholar.google.co.uk

nih.gov

pubmed.ncbi.nlm.nih.gov

  • Prisinzano TE (2005). „Psychopharmacology of the hallucinogenic sage Salvia divinorum“. Life Sci. 78 (5): 527–31. doi:10.1016/j.lfs.2005.09.008. PMID 16213533.
  • Harding, Wayne W.; Schmidt, Matthew; Tidgewell, Kevin; Kannan, Pavitra; Holden, Kenneth G.; Gilmour, Brian; Navarro, Hernan; Rothman, Richard B.; Prisinzano, Thomas E. (2006-01-01). „Synthetic Studies of Neoclerodane Diterpenes from Salvia d ivinorum : Semisynthesis of Salvinicins A and B and Other Chemical Transformations of Salvinorin A“. Journal of Natural Products. 69 (1): 107–112. doi:10.1021/np050398i. ISSN 0163-3864. PMC 2544632. PMID 16441078.
  • Imanshahidi M, Hosseinzadeh H (2006). „The pharmacological effects of Salvia species on the central nervous system“. Phytother Res. 20 (6): 427–37. doi:10.1002/ptr.1898. PMID 16619340.
  • Zhang Y, Butelman ER, Schlussman SD, Ho A, Kreek MJ (2005). „Effects of the plant-derived hallucinogen salvinorin A on basal dopamine levels in the caudate putamen and in a conditioned place aversion assay in mice: agonist actions at kappa opioid receptors“. Psychopharmacology (Berl.). 179 (3): 551–8. doi:10.1007/s00213-004-2087-0. PMID 15682306.{{cite journal}}: CS1 priežiūra: multiple names: authors list (link)
  • Mowry M, Mosher M, Briner W (2003). „Acute physiologic and chronic histologic changes in rats and mice exposed to the unique hallucinogen salvinorin A“ (PDF). J Psychoactive Drugs. 35 (3): 379–82. PMID 14621136.{{cite journal}}: CS1 priežiūra: multiple names: authors list (link)
  • Bigham AK, Munro TA, Rizzacasa MA, Robins-Browne RM (2003). „Divinatorins A-C, new neoclerodane diterpenoids from the controlled sage Salvia divinorum“. J. Nat. Prod. 66 (9): 1242–4. doi:10.1021/np030313i. PMID 14510607.{{cite journal}}: CS1 priežiūra: multiple names: authors list (link)
  • Munro TA, Rizzacasa MA (2003). „Salvinorins D-F, new neoclerodane diterpenoids from Salvia divinorum, and an improved method for the isolation of salvinorin A“. J. Nat. Prod. 66 (5): 703–5. doi:10.1021/np0205699. PMID 12762813.
  • Scheerer JR, Lawrence JF, Wang GC, Evans DA (2007). „Asymmetric synthesis of salvinorin A, a potent kappa opioid receptor agonist“. J. Am. Chem. Soc. 129 (29): 8968–9. doi:10.1021/ja073590a. PMID 17602636.{{cite journal}}: CS1 priežiūra: multiple names: authors list (link)

ncbi.nlm.nih.gov

sagewisdom.org

web.archive.org

worldcat.org